Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$16.3K Hold
458
﹤0.01% 312
2023
Q1
$16.3K Hold
458
﹤0.01% 308
2022
Q4
$16K Hold
458
﹤0.01% 304
2022
Q3
$13K Sell
458
-107
-19% -$4.05K ﹤0.01% 318
2022
Q2
$31K Hold
565
﹤0.01% 260
2022
Q1
$31K Hold
565
﹤0.01% 273
2021
Q4
$27K Hold
565
﹤0.01% 298
2021
Q3
$27K Hold
565
﹤0.01% 298
2021
Q2
$28K Hold
565
﹤0.01% 294
2021
Q1
$25K Hold
565
0.01% 281
2020
Q4
$26K Sell
565
-215
-28% -$9.88K 0.01% 251
2020
Q3
$37K Hold
780
0.01% 214
2020
Q2
$39K Buy
780
+215
+38% +$11K 0.01% 207
2020
Q1
$27K Hold
565
0.01% 213
2019
Q4
$33K Hold
565
0.02% 226
2019
Q3
$30K Hold
565
0.02% 232
2019
Q2
$28K Hold
565
0.01% 247
2019
Q1
$30K Hold
565
0.01% 245
2018
Q4
$27K Hold
565
0.01% 258
2018
Q3
$28K Hold
565
0.01% 252
2018
Q2
$28K Sell
565
-54
-9% -$2.72K 0.01% 256
2018
Q1
$30.2K Hold
619
0.02% 253
2017
Q4
$28K Hold
619
0.02% 256
2017
Q3
$32K Sell
619
-92
-13% -$4.67K 0.02% 238
2017
Q2
$38K Buy
711
+49
+7% +$2.61K 0.02% 227
2017
Q1
$35K Hold
662
0.02% 231
2016
Q4
$32K Buy
+662
New +$32.7K 0.03% 232

Other funds holding GSK

First Command Bank's GSK Position: Q2 2023 in Review

First Command Bank held its GSK (GSK) position steady in Q2 2023 at 458 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #312.

First Command Bank first reported a position in GSK in Q4 2016 and has held it in 27 quarters since. The position peaked at $39K in Q2 2020. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

  • First Command Bank held 458 shares of GSK worth $16.3K as of Q2 2023.
  • First Command Bank left its GSK share count unchanged in Q2 2023.
  • GSK made up ﹤0.01% of First Command Bank's portfolio in Q2 2023, its #312 holding.
  • First Command Bank first reported a position in GSK in Q4 2016 and has held it in 27 quarters since.
  • First Command Bank's GSK position peaked at $39K in Q2 2020.
  • 827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on First Command Bank's 13F filing for Q2 2023, filed 21 Jul 2023.